ABSTRACT
Introduction:
Vincristine (VCR), an alkaloid is isolated from Vinca rosea Linn. The property of VCR to inhibit cell division through prevention of polymerization of tubulin of the microtubules which constitute the spindle fibre, and dissociation of the existing microtubules leads to the extensive use of vincristine in the chemotherapy against several kinds of cancers [1] . Treatment with combination chemotherapeutic regimens for cancer leading to severe male reproductive dysfunction including azoospermia/oligospermia, gynaecomastia and lack of sexual desire and libido has already been reported [2] and vincristine is one of the constant ingredients in most of such regimens. Vincristine as a causative agent of male reproductive toxicity, particularly affecting Spermatogenesis as well as androgenesis of the testis, has already been studied [3] [4] [5] . Spermatogenesis is required for the formation and maturation of sperms which is controlled by the male sex hormone i.e. testosterone.
Testosterone is produced by the steroidogenesis which utilizes Cholesterol and different enzymes act on it to form testosterone [6, 7] . StAR is the protein which is involved in transport of cholesterol from outer mitochondrial membrane to inner mitochondrial membrane. The mitochondrial cholesterol side chain cleavage enzyme (P450scc) converts this cholesterol into pregnenolone which in turn is converted to testosterone by enzymes in the smooth endoplasmic reticulum; 3β-hydroxysteroid dehydrogenase (3β-HSD), 17 enzyme in the steroidogenesis pathway and is a key enzyme responsible for the conversion of testosterone to estradiol [8] . The androgen receptor on binding to testosterone gets activated and regulates the transcription of several genes required for the process of spermatogenesis [9, 10] . Vincristine affects the spermatogenic compartment in a dose dependent as well as duration Dependent manner [11] .
Studies have been reported that VCR affects the structural and functional integrity of Sertoli cells through the effect on microtubules [3, 12] . Leydig cell atrophy has also been observed, which results in the decrease in the circulating level of androgens [13] .
Vincristine has been shown to disrupt the sperm's axoneme and dense fibrils [14] which are important component of the sperm's flagellum resulting in compromised motility in sperms [15] . It was already investigated that VCR treatment results in the decrease in the testosterone production resulting in the faulty spermatogenesis causing male infertility [13, 16] . Though it is known that VCR treatment results in decreasing level of testosterone there is no possible mechanism to elucidate the reason of decrease testosterone level. The possibility of Steroidogenic pathway might have hampered upon vincristine treatment cannot be ruled out. Hence present study aims to study the expression of genes involved in steroidogenic pathway which includes StAR protein, P450scc, 3β HSD, P450C17, 17 β-HSD and aromatase. Further the expression of receptors that is androgen receptor which is required for mediating the effect of testosterone on treatment with VCR is also studied. Animals were assigned to treatment and control groups (5 rats per group) and were allowed free access to food and water ad libitum (Amrut feed Ltd).The room temperature of 250C and the light/dark cycle of 12hrs were maintained.
Drug treatment
Vincristine sulphate (Cytocristin; Goa Cipla Ltd, India) was purchased from a local drug house. The control group received a daily dose of 0.5 ml of physiological saline while the experimental rats received (five rats) 40μg VCR/kg/day through the intraperitoneally in constant volume of 0.5 ml of physiological saline for 30 days via intraperitoneal route.
Extraction of RNA
Total RNA was extracted from the testes using the RNeasy Mini Kit obtained from 
Reverse transcription polymerase chain reaction
Semi-Quantitative One
Step RT-PCR was performed using 500 ng RNA template, in which RNA was first reverse transcribed to cDNA and then Polymerase chain reaction was carried out in a final volume of 25 μL. For Primer sequence and conditions for amplification are shown in Table 
Extraction of Protein and Western Blotting
Protein was extracted using around 500 mg of testicular tissue and homogenised in 5 ml of lysis buffer (50mM Tris-Cl, 150mM NaCl, 1mM EDTA, 1mM PMSF, 1% Triton X-100). The homogenate was allowed to stand on ice for 15minutes and then was centrifuged at 10,000 rpm at 4°C for 40 minutes. The supernatant containing proteins were used for further study. The concentration of protein was determined by Lowry 
Statistical Analysis
The data was represented as the mean ± standard error of the mean (S.E.M) and was analysed by using independent Student t test. The differences in the control and treated groups were considered significant at P<0.05.
Results

Body and testicular weights
Vincristine treatment at a dose of 40μg/kg/day for a period of 30 days was studied.
The body weights of control and treated groups were monitored on a weekly basis during the treatment period for assessment of effects on the general health. Although there was a decreasing trend seen in the body weight each week, the body weight of the rats at the end of the treatment was not significantly altered as compared to the control rats (Table 2 
Discussion
Vincristine, a potent anticancer drug has been shown to have adverse effect on the male reproductive system. In the present study, Vincristine administration did not alter the testis weight significantly although a slight reduction in the body weight was observed. The body weight reduction can be attributed to the general toxicity of vincristine.
The alterations in the level of testosterone could be probably due to the effect of the vincristine on the key proteins and enzymes of the steroidogenic pathway.
Steroidogenic pathway involves the delivery of the substrate, cholesterol from the outer to the inner mitochondrial membrane, by StAR [18, 19] , which is the rate limiting step in steroidogenesis [20] . The cholesterol side chain cleavage enzyme P450scc converts cholesterol to pregnenolone, the first committed step in the process [21, 22] which is subsequently catalysed to progesterone by 3β hydroxysteroid dehydrogenase (3β-HSD) [23] . Progesterone is then converted to androstenedione by cytochrome P450 C17-20 lyase, and then to testosterone by 17β hydroxysteroid dehydrogenase (17β HSD). Leydig, Sertoli and germ cells further express low levels of aromatase, which converts testosterone originating from the Leydig cells into estradiol, a step that appears to be necessary for the successful initiation of spermatogenesis and mitosis of spermatogonia [24] . Testosterone synthesis is regulated by LH which binds to LH receptors and induces cAMP signalling pathway.
The cAMP in turn binds to cAMP responsive element in the promoter [25] and of steroidogenesis has been obtained from both basic and clinical studies [26, 27] .
Decrease in the expression of StAR results in reduced cholesterol transfer to P450scc
within the mitochondria which leads to suppression of steroid biosynthesis [28, 29] .
The decrease in the level of StAR protein on vincristine treatment might affect the transfer of cholesterol from outer to inner mitochondrial membrane, thus leading to reduction in testosterone level as reported earlier [30, 31, 32] . In males, testosterone levels are maintained by feedback mechanism, wherein the LH secreted by the pituitary binds to LH receptor [33] and activates the cAMP signalling pathway for synthesis of androgen [34] . The high levels of LH on treatment with vincristine [35, 36] should have activated the cAMP signalling pathway thereby inducing the expression of genes involved in the process of steroidogenesis. However in the present study, there is decrease in StAR mRNA and protein on vincristine treatment which probably could be due to altered cAMP signalling because of low levels of LH receptors, as seen on treatment with the cytotoxic drug, cis-platin [37] . Some studies have also demonstrated that the inhibition of StAR mRNA or protein levels results in a dramatic decrease in steroid biosynthesis which is incongruence with present study [38, 39] . Once testosterone enters inside the mitochondria, P450scc converts cholesterol into pregnenolone which is further converted into progesterone by 3β-HSD6. There are no significant changes in mRNA expression levels of P450scc and 3β-HSD on vincristine. A similar observation was also reported by Namasivayam and his coworkers [40] in cyclophosphamide treated male rats.
The lack of significant alterations in P450scc and 3β-HSD expression levels could be possibly due to the fact that they are chronologically regulated and possess long half life [41] . Unaltered expression of P450c17 and Aromatase indicates that probably an alternative pathway or other factors apart from the cAMP signalling pathway regulates the transcription of this gene. Testosterone mediates its effect by binding to the androgen receptor [42] . In the rat testis, AR protein has been localised to Sertoli 
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